Joshua Roffman, MD, MMSc, is the director of research in the Schizophrenia Clinical and Research Program and the co-director of Mass General Neuroscience. His recent research leveraged the folic acid fortification of the American grain supply in the mid-1990s as a natural experiment to study its effect on brain development. They found that folic acid exposure in utero was associated with brain changes that appear to be protective against risk for schizophrenia.
Read more here:
Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.